
PDGFR
PDGFR (platelet-derived growth factor receptor) inhibitors are compounds that block the signaling of PDGFR, a receptor involved in cell growth, proliferation, and angiogenesis. PDGFR plays a significant role in the development of the blood vessels that supply tumors. Inhibiting PDGFR can therefore prevent angiogenesis, making these inhibitors valuable in cancer therapy. At CymitQuimica, we provide a selection of high-quality PDGFR inhibitors to support your research in oncology, vascular biology, and angiogenesis.
Found 127 products of "PDGFR"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
GW 2580
CAS:Formula:C20H22N4O3Purity:>98.0%(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:366.42Sorafenib Tosylate
CAS:Formula:C21H16ClF3N4O3·C7H8O3SPurity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:637.03Imatinib Mesylate
CAS:Formula:C29H31N7O·CH4O3SPurity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:589.72Imatinib
CAS:Formula:C29H31N7OPurity:>98.0%(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:493.62TCS 359
CAS:Formula:C18H20N2O4SPurity:>98.0%(HPLC)Color and Shape:Light yellow to Brown powder to crystalMolecular weight:360.43Dasatinib
CAS:Formula:C22H26ClN7O2SPurity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:488.01Sunitinib Malate
CAS:Sunitinib Malate (Sunitinib) is an indolinone-based tyrosine kinase inhibitor.Formula:C26H33FN4O7Purity:98% - 99.26%Color and Shape:SolidMolecular weight:532.56Trapidil
CAS:Trapidil (Avantrin) is a coronary vasodilator agent.Formula:C10H15N5Purity:99.42%Color and Shape:SolidMolecular weight:205.26Lenvatinib
CAS:Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, and RET, and has oral activity.Formula:C21H19ClN4O4Purity:98.46% - 99.96%Color and Shape:SolidMolecular weight:426.85N-Desmethyl imatinib
CAS:N-Desmethyl imatinib (Imatinib metabolite N-Desmethyl imatinib) is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.Formula:C28H29N7OPurity:98.60%Color and Shape:Off-White To Pale-Yellow SolidMolecular weight:479.58Ref: TM-T11641
1mg87.00€5mg166.00€10mg303.00€25mg512.00€50mg737.00€100mg1,018.00€1mL*10mM (DMSO)170.00€Regorafénib N-oxyde (M2)
CAS:Regorafénib N-oxyde M2 is an active metabolite of Regorafenib.
Formula:C21H15ClF4N4O4Purity:98.03% - 98.26%Color and Shape:SolidMolecular weight:498.81Olaratumab
CAS:Olaratumab(IMC-3G3) is a human monoclonal IgG1 antibody against platelet-derived growth factor receptor alpha (PDGFRα), which has antitumor effects and can be
Purity:SDS-PAGE:95% SEC-HPLC:98.70%Color and Shape:LiquidMolecular weight:147.12 kDaJNJ-10198409
CAS:JNJ-10198409: selective ATP competitive PDGF-RTK inhibitor; IC50: PDGFR-β 4.2 nM, PDGFR-α 45 nM; antiangiogenic & antiproliferative.Formula:C18H16FN3O2Purity:98.51%Color and Shape:SolidMolecular weight:325.34Ref: TM-T15616
1mg33.00€5mg92.00€10mg122.00€25mg198.00€50mg294.00€100mg419.00€200mg587.00€1mL*10mM (DMSO)92.00€Sunitinib
CAS:Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that inhibits VEGFR2 and PDGFRβ (IC50=80/2 nM).Formula:C22H27FN4O2Purity:98% - 99.67%Color and Shape:Yellow SolidMolecular weight:398.474-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide
CAS:Formula:C29H31N7OPurity:98%Color and Shape:SolidMolecular weight:493.6027Ref: IN-DA00350H
1g25.00€5g33.00€10g56.00€1kg506.00€25g61.00€5kgTo inquire100g164.00€10kgTo inquire500g687.00€2-(3,4-Dimethoxyphenylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
CAS:Formula:C18H20N2O4SPurity:95%Color and Shape:SolidMolecular weight:360.4274AG 1295
CAS:AG 1295 is a selective PDGFR tyrosine-kinase inhibitor; it blocks PDGFR autophosphorylation without affecting EGF receptor.Formula:C16H14N2Purity:99.64%Color and Shape:SolidMolecular weight:234.3Imatinib Mesylate
CAS:Imatinib Mesylate (STI-571) is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR,
Formula:C29H31N7O·CH4SO3Purity:98% - >99.99%Color and Shape:White Crystalline PowderMolecular weight:589.71



